ProfileGDS5678 / 1435470_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 4% 4% 4% 8% 4% 4% 4% 5% 5% 4% 4% 5% 4% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.039024
GSM967853U87-EV human glioblastoma xenograft - Control 22.012524
GSM967854U87-EV human glioblastoma xenograft - Control 32.01274
GSM967855U87-EV human glioblastoma xenograft - Control 42.140018
GSM967856U87-EV human glioblastoma xenograft - Control 51.977264
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.05114
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.033694
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.033465
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.030285
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.993294
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.997984
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.061745
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.99964
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.970923